Prophylactic azathioprine after ileocolic resection
What is the evidence that prophylactic azathioprine reduces the rate of symptomatic recurrence after ileocolic resection in CD
What is known
- The postoperative CD literature reports early prophylaxis reduces clinical and endoscopic recurrence but that surgical-recurrence results have been conflicting. 1
- In a retrospective high-risk cohort, both immediate and endoscopy-driven azathioprine delayed and reduced surgical recurrence versus symptom-driven initiation; immediate was not superior to endoscopy-driven. 1
- A prospective long-term observational study reported favorable endoscopic/clinical outcomes on immediate postoperative azathioprine, though many still developed anastomotic lesions. 2
- A review noted the efficacy of azathioprine and 6-mercaptopurine for preventing postoperative recurrence remains uncertain. 3
What is unknown / caveats
- Field explicitly reports conflicting results for surgical recurrence 1
- Azathioprine efficacy for postoperative prevention described elsewhere as remaining uncertain 3
- Retrieved primary data are largely retrospective/observational cohorts, not RCTs
- Most studies emphasize endoscopic/clinical rather than symptomatic recurrence as a distinct endpoint
- The retrieved chunks do not isolate symptomatic (clinical) recurrence from surgical or endoscopic endpoints in a pooled, comparable way.
References
- [No authors listed]. Immediate prophylactic vs endoscopic or symptomatic-driven azathioprine treatment to prevent surgical recurrence after intestinal resection for Crohn's disease. Colorectal Dis. 2018;20(9):O267-O276. PMID: 30051962.
- [No authors listed]. Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: results of a prospective, observational, long-term follow-up study. Inflamm Bowel Dis. 2008;14(4):508-13. PMID: 18183602.
- [No authors listed]. Postoperative Crohn's disease. Inflamm Bowel Dis. 2005;11(8):765-77. PMID: 16043993.
For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.
⚠ Required context not in this corpus (moderate). Colonoscopy at 6 months after resection with treatment STEP-UP for recurrence beat drug therapy alone in a randomised trial (POCER, De Cruz 2015, PMID 25542620). Active endoscopic monitoring is part of the strategy, not optional follow-up.
Why this matters: Naming a prophylactic drug without the 6-month endoscopic reassessment omits half of the only strategy shown superior in a randomised trial.
Added by the landmark interlock. This corpus is surgical in scope and cannot admit the source paper (PMID 25542620). Not generated by the RAG.
Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.
Reviewer notes